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Background: The role of miR-1 and miR-133 in regulating the expression of 
potassium and calcium ion channels, and mediating cardiomyocyte apoptosis in mice 
with viral myocarditis (VMC) is investigated herein. 
Methods: Male Balb/c mice were randomly divided into groups:  control group, 
VMC group, VMC + miR-1/133 mimics group, or VMC + miR-1/133 negative 
control (NC) group. VMC was induced with coxsackievirus B3 (CVB3). MiR-1/133 
mimics ameliorated cardiac dysfunction in VMC mice and was compared to the 
VMC+NC group. 
Results: Haematoxylin and eosin (H&E) staining showed a well-arranged 
myocardium without inflammatory cell infiltration in the myocardial matrix of the 
control group. However, in the VMC and VMC+NC groups, the myocardium was 
disorganized and swollen with necrosis, and the myocardial matrix was infiltrated 
with inflammatory cells. These changes were alleviated by miR-1/133 mimics. 
TUNEL staining revealed decreased cardiomyocyte apoptosis in the VMC + 
miR-1/133 mimics group compared with the VMC group. In addition, miR-1/133 
mimics up-regulated the expression of miR-1 and miR-133, the potassium channel 
genes Kcnd2 and Kcnj2, as well as Bcl-2, and down-regulated the expression of the 
potassium channel suppressor gene Irx5, L-type calcium channel subunit gene α1c 
(Cacna1c), Bax, and caspase-9 (Casp9) in the myocardium of VMC mice. MiR-1/133 
also up-regulated the protein levels of Kv4.2 and Kir2.1, and down-regulated the 
expression of CaV1.2 in the myocardium of VMC mice. 
Conclusions: MiR-1 and miR-133 decreased cardiomyocyte apoptosis by mediating 
the expression of apoptosis-related genes in the hearts of VMC mice. 




MicroRNA (miR)-1 and miR-133 are members of a miRNA cluster expressed 
exclusively in skeletal and cardiac muscle cells [1], and are essential for heart 
development [2]. MiR-1 and miR-133 have been shown to regulate the expression of 
gap junctions [3], pacemaker channels [4] and potassium (K+) channels, including 
inward-rectifying Kir2.1, which stabilizes resting potential [5] and Kv4.2, which 
dominates the outward-transient current (Ito) [6]. In addition, miR-133 has been 
shown to target CaV1.2, the primary α-subunit for L-type calcium (Ca2+) channels 
underlying cardiac excitability [7]. Previous studies have shown that approximately 20% 
of infant deaths due to fatal arrhythmia and severe heart failure were caused by acute 
severe viral myocarditis (VMC), mainly caused by coxsackievirus B3 (CVB3) [8]. 
However, there is currently a lack of effective etiological treatment for severe VMC. 
Introducing miR-1/133 can reduce virus escape and mutation, and as such, one of the 
major treatments involves the use of RNA interference (RNAi) combined with miR 
mimics [9, 10]. A previous study showed that approximately 20% of miR-1/133 mimics, 
labeled with Dy547 and packaged in RNA-LANCEr II neutral ionic lipids, arrived in 
cardiomyocytes and exhibited intracellular Dy547 particle signals when administered 
by tail vein injection [10]. In addition, miR-133 has been shown to target caspase-9, a 
pro-apoptotic factor, and promotes cardiac cell apoptosis by interfering with the 
expression of mRNA [11]. 
With rapid advances in molecular biology, miRs have been widely studied in 
different fields. However, reports regarding the effects of miRs on VMC have been 
limited. Under investigation in the present study, was the impact of miR-1/133 mimics 
and the appropriate miR-1/133 negative control on a mouse model of acute VMC, and 




This study was in accordance with the National Research Council Guide for the 
care and use of laboratory animals. The animal experiments in this study were 
performed with approval by the Animal Care Committee of the Medical School of 
Shandong University. 
 
Mouse model of acute VMC and interference 
CVB3 was passaged in HeLa cells by transfection as described previously [12]. 
Virus titer was determined using a tissue culture infective dose 50 (TCID50) assay at 
the beginning of the experiments. HeLa cells were cultured in Dulbecco’s Modified 
Eagle medium (DMEM, Life Technologies, USA) supplemented with fetal bovine 
serum (10%; Gibco, Australia) and penicillin-streptomycin (100 IU/mL; Invitrogen, 
USA). 
Forty healthy male Balb/c mice (6–8 weeks old) were randomly divided into four 
groups: control group (n = 10), in which mice were injected intraperitoneally with 
Eagle’s medium (0.1 mL); VMC group (n = 10), in which VMC was induced by 
intraperitoneal injection of 104 TCID50 CVB3 (0.1 mL); VMC + miR-1/133 mimics 
group (n = 10), in which VMC mice were injected intraperitoneally with miR-1/133 
mimics (1 µg/g, GenePharma, Shanghai, China) on the day following VMC induction; 
VMC + NC group (n = 10), in which VMC mice were injected intraperitoneally with 
miR-1/133 NC (1 µg/g, GenePharma, Shanghai, China) via the tail vein on the day 
following VMC induction.  
MiR-1/133 mimics, which were composed of mmu-miR-1 mimics and 
mmu-miR-133 mimics, were packaged in Lipofectamine 2000 Reagent (Invitrogen, 
US), and then directly mixed in the ultrasonic field to improve targeting ability.  
Feeding conditions of mice in each group were the same. Following virus injection, the 
diet, activity level, and coat appearance of the mice were observed on a daily basis. 
 
Cardiac functional analysis  
On the 7th day following establishment of the VMC model, i.e. the sixth day after 
mir-1/133 intervention, mice were anesthetized with an intraperitoneal injection of 
chloral hydrate (10%, 4 mg/g). After the mice were fixed in a supine position, the 
chest was shaved, and an M-echocardiograph was performed to measure the left 
ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) 
of the mice in each group. 
 
Specimen collection and disposition 
On the 7th day after modeling, after all mice in the groups were anesthetized, their 
hearts were removed under sterile conditions, washed with normal saline, and then 
weighed. Half of each heart of the mice were frozen with liquid nitrogen and stored at –
80C for use in molecular biological experiments (half of each heart was used for 
quantitative reverse transcription followed by polymerase chain reaction (qRT-PCR) 
and western blot, which were carried out by two people), the other half of the heart 
were fixed in 10% neutral formaldehyde, embedded in paraffin, and sectioned at 4.5 
µm intervals for histological study (HE staining and TUNEL staining). 
 
Hematoxylin and eosin staining 
Tissue sections were stained by hematoxylin and eosin (H&E; Beyotime, Shanghai, 




Cardiomyocyte apoptosis was detected by terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL) staining according to the manufacturer protocol 
(Roche, USA). Ten randomly selected fields from each slide were scored at a high 
magnification. The ratio of the number of brown cells, i.e. apoptotic cells, to a total of 
30 cardiomyocytes counted per field was defined as the myocardial cell apoptotic 
ratio.  
 
Quantitative real time RT-PCR 
Total RNA was extracted from a part of each of frozen mouse heart using a TRIzol 
reagent (Ambion, USA). According to the manufacturer protocol (Thermo Scientific, 
USA), qRT-PCR was performed to detect the expression of miR-1 and miR-133, 
inward rectifier potassium current (Ik1) channel gene Kcnd2, its transcription repressor 
Irx5, transient outward potassium current (Ito) channel gene Kcnj2, the L-type calcium 
channel subunit α1c (Cacna1c), and apoptosis-related genes Bax, Bcl-2 and caspase-9 
(Casp9) using an ABI 7500 real-time PCR system. β-actin was used as a reference for 
gene expression and U6 was used as a reference for expression of miR-1 and miR-133. 
The relative expression of genes was calculated using the 2–∆∆Ct method. The primers 
were synthesized by Guangzhou Saibo Corp, China. The sequences of gene primers 
used in the present study are shown in Table 1. 
 
Western blot 
To examine protein levels of Kv4.2, Kir2.1, and CaV1.2, total protein lysates were 
purified from the rest of frozen heart samples using RIPA buffer (Beyotime, Shanghai, 
China). A bicinchoninic acid (BCA) protein assay kit (Beyotime, Shanghai, China) 
was used to determine protein concentration. Protein (30–50 µg) was separated on an 
8–15% gel with sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) and transferred to a polyvinylidene fluoride (PVDF) membrane. The 
membrane was then blocked in 5% milk, followed by incubation at 4C overnight with 
the primary antibodies of interest (rabbit polyclonal anti-Kv4.2 and anti-Kir2.1, Bioss, 
Beijing, China, diluted 1:300; mouse monoclonal anti-CACNA1C, Abcam, USA; and 
mouse anti-GAPDH, ZSGB-BIO Beijing, China, diluted 1:1000). Membranes were 
then washed (3 times) with tris-buffered saline with Tween (TBST), and incubated with 
the appropriate secondary antibodies (ZSGB-BIO Beijing, China, diluted 1:10000). 
Immunoreactive bands were detected by enhanced chemiluminescence (ECL; 
Millipore, USA) and quantified using C-digit (Model: 3600, Image Studio Digits Ver 
4.0, Licor, Lincoln, NE, USA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
was used as a reference loading control. Data were collected from at least three 
independent experiments. 
 Data analysis 
The experimental data are presented as mean ± standard error (SE). Statistical 
comparisons in multiple groups were performed using one-way analysis of variance 
(ANOVA), and the comparison between two groups was performed with the Fisher 




MiR-1/133 mimics improved general status of VMC mice 
Compared with mice in the control group, on the third day following CVB3 
injection, mice in the VMC group and in the VMC + NC group had disordered fur, were 
irritated easily or insensitive to irritation, ate little food and lost weight (data not 
shown). These conditions were improved in mice receiving the miR-1/133 mimics 
(data not shown). Figure 1A shows the specific myocardial staining, shown using 
antibodies against -actinin (green) and miR-1/133 (red). 
The hearts from mice in the VMC group and NC group were bigger than those in the 
control and VMC + miR-1/133 mimics groups (Fig. 1B) and heart weight/body weight 
ratio was increased as well (Fig. 1C). There were also spot-like necrotic areas on the 
surface of the hearts of mice in the VMC group and the VMC+NC group (Fig. 1B).  
 
MiR-1/133 mimics improved cardiac function of VMC mice 
Compared with those in the control group, EF and FS of mice in the VMC and 
VMC + NC groups were significantly decreased (*p < 0.01), suggesting impaired 
cardiac function of VMC mice. However, treatment with miR-1/133 mimics improved 
EF and FS of VMC mice (#p < 0.05, ##p < 0.01; Fig. 2). 
 
MiR-1/133 mimics attenuated pathological changes of VMC hearts 
Compared with control group hearts, H&E staining showed that myocardia in 
VMC and VMC + NC groups were swollen and disordered, they were also infiltrated 
by inflammatory cells in the myocardial matrix. MiR-1/133 mimics reduced the edema 
of cardiomyocytes, improved arrangements, and diminished inflammatory cell 
infiltrate in the myocardial matrix (Fig. 3A). 
 MiR-1/133 mimics reduced cardiomyocyte apoptosis  
TUNEL staining showed increased numbers of brown nuclei in the VMC and VMC 
+ NC groups compared with those in the control group (**p < 0.01), revealing 
increased cell death. MiR-1/133 mimics significantly reduced the number of brown 
nuclei (##p < 0.01), indicating decreased cell death. The VMC+NC group had the 
highest rate of apoptosis while the control group had the lowest (Fig. 3B, C). 
 
MiR-1/133 mimics improved expression of miR-1 and miR-133 in VMC hearts 
qRT-PCR data showed that the relative expression of miR-1 and miR-133 in mouse 
hearts of the VMC and VMC + NC groups was significantly decreased compared to the 
control group (*p < 0.05), but miR-1/133 mimics increased the expression of miR-1 
and miR-133 (#p < 0.05; Fig. 4A). 
 
MiR-1/133 regulated the mRNA expression of apoptosis-related genes Bax, Bcl-2 and 
caspase-9 in VMC hearts 
The relative expression of pro-apoptosis-related genes Bax (**p < 0.01), and Casp9 
(**p < 0.05) mRNA in the VMC and VMC + NC groups were significantly 
up-regulated compared with those in the control group. However, miR-1/133 mimics 
greatly decreased their expression (#p < 0.05). While the expression of the 
anti-apoptosis-related gene Bcl-2 mRNA was down-regulated in the VMC and 
VMC+NC groups, miR-1/133 mimics increased its expression (p < 0.05; Fig. 4B). 
 
MiR-1/133 regulated the relative expressions of ion channel genes Kcnd2, Kcnj2, Irx5 
and á1c in VMC hearts 
Compared with those in the control group, the relative expression of Kcnd2 and 
Kcnj2 in the VMC and VMC + NC groups were significantly down-regulated as 
revealed by qRT-PCR data (*p < 0.05), which was attenuated by miR-1/133 mimics 
interference (#p < 0.05). Also, the relative expression of Irx5 and α1c (Cacna1c) was 
increased in VMC and VMC + NC groups compared with the control group (*p < 0.01), 
and this increase was suppressed by miR-1/133 mimics interference (#p < 0.05; Fig. 
4C). 
 
MiR-1/133 regulated the protein levels of Kv4.2, Kir2.1 and L-type calcium channel 
subunit CaV1.2 in VMC hearts 
Compared with control mice, the protein levels of Ito target protein Kv4.2 and Ik1 
target protein Kir2.1 in the VMC and VMC + NC groups were significantly decreased 
(*p < 0.05), but this decrease was suppressed by miR-1/133 mimics. Also, the 
expression of the L-type calcium channel subunit protein CaV1.2 was significantly 
increased in the VMC and VMC+NC groups compared with the control group (#p < 
0.01), but again, this increase was attenuated by miR-1/133 mimics interference (#p < 
0.05; Fig. 5). 
 
Discussion 
MiRs have been shown to be implicated in a variety of human diseases, and may 
serve as potential bio-markers in certain diseases once released into the circulatory 
system [13]. Currently, more than 100 miRs have been identified in myocardial cells, 
and some, if not all, were dysregulated in heart diseases [14, 15]. MiR-1 and miR-133, 
which translate together in a bicistronic way [16], are specific to muscle and are 
abundant in the heart [17, 18]. MiR-1 and miR-133 play an important role in normal 
cardio genesis [19] and in the pathogenesis of several cardiovascular diseases including 
myocardial ischemia-reperfusion injury [11], cardiac hypertrophy [20, 21], arrhythmia 
[22], and myocardial infarction [23]. However, their involvement in VMC-linked 
cardiac phenotypes has not been explored. The major findings from the present 
investigation include: 1) miR-1/133 was downregulated in the hearts of VMC mice, 2) 
miR-1/133 mimics attenuated cardiac dysfunction and apoptosis in VMC mouse hearts, 
3) miR-1/133 mimics mediated the expression of apoptosis-related genes in VMC 
mouse hearts, and 4) miR-1/133 mimics mediated the expression of potassium and 
calcium channels in VMC mouse hearts.  
Viral invasion of myocardial cells causes persistent chronic inflammation, 
subsequently resulting in myocardial cell hypertrophy, myocardial cell apoptosis, and 
myocardial fibrosis [24–26]. Therefore, the progression of VMC will eventually lead 
to heart failure and fatal arrhythmias, which is linked to sudden death. In agreement 
with the above findings, in the present study, the VMC mice induced by CVB3 
exhibited impaired cardiac function as evidenced by reduced EF and FS compared 
with control mice. Under further testing the effects of miR1/133 on cardiac function 
and pathology in VMC mice, and found that miR-1/133 mimics ameliorated cardiac 
function and pathological changes of VMC mice. This miR-1/133-induced 
improvement of cardiac function and pathology might be attributed to decreased 
cardiomyocyte apoptosis in VMC mouse hearts. To further understand the molecular 
basis underlying reduced apoptosis by miR-1/133 mimics, qRT-PCR was used to 
examine the relative expression of apoptosis-related genes Bax, Bcl-2 and Casp9 in 
VMC hearts of the different groups. The pro-apoptosis-related genes Bax and Casp9, 
as well as the anti-apoptosis-related gene Bcl-2 are the main genes involved in the 
progression of cell apoptosis. The present findings suggest that viral infection 
increased the expression of Bax and Casp9 but decreased the expression of Bcl-2, and 
that miR-1/133 mimics attenuated the changes in the expression of these three genes. 
Therefore, it is possible that these miR1/133-induced changes contributed to the 
improved cardiac function and pathology of VMC mice by miR1/133 mimics. In 
addition, the current findings demonstrate that miR-133 expression was inversely 
proportional with the expression of Casp9 and was in line with a previous study 
identifying caspase-9 as a target of miR-133 [27].  
Viral myocarditis patients display different arrhythmias, and severe arrhythmia 
can cause sudden cardiac death. Electrical remodeling and myocardium structural 
remodeling are the main mechanisms leading to arrhythmia [28], which is associated 
with changes in the activity of ion channels present on the myocardial cell membrane 
[29], including potassium and calcium ion channels. Although many miRs are 
expressed abnormally in many heart diseases, there are few reports regarding the 
relationship between miR-1 and miR-133 and the activity of potassium ion channels 
and calcium ion channels in VMC. For example, miR-1 and miR-133 were shown to be 
involved in the regulation of Kv4.2 and Kir2.1 expression [30], the latter of which is the 
main component of Ik1 and is linked to arrhythmia [31]. Also, the aberrant expression of 
miR-1 influenced the activity of Ik1 and its expression [32, 33]. Kir2.1, which is the 
main potassium channel subunit,plays important roles in initiating and maintaining 
resting membrane potential of cardiomyocytes [34], is encoded by Kcnj2, and Kcnj2 
was targeted by miR-1 [3]. Therefore, the aberrant expression of miR-1 could cause 
abnormality in the structure and function of potassium channels, influencing 
membrane potential stability, and result in arrhythmia. In addition, the potassium 
channel subunit Kv4.2, the main component of Ito, is rich in cardiomyocytes, and is 
encoded by the Kcnd2 gene. Irx5, a transcriptional repressor of Kcnd2, and regulated 
potassium ion current and repolarization of action potentials. MiR-1 was found to 
target Irx5 and thus influenced the expression of Kcnd2 [35]. In the present study, it 
was observed that the aberrant expression of Kcnd2 and Kcnj2 in VMC 
cardiomyocytes, which can result in a change of potassium ion concentration and 
influence membrane potential, and therefore may contribute to arrhythmia. In line 
with the above reports, it was  also shown herein that there was a negative correlation 
between miR-1 and Irx5. Therefore, it was believed that miR-1 improved arrhythmia 
at least in part through mediating the expression of Kcnd2 and Kcnj2 and thus, 
regulating potassium concentrations. In addition, the L-type calcium channel subunit 
α1c is the main calcium ion channel in myocardium and plays an important role in 
stabilizing calcium concentration in the cell and maintaining action potential 
repolarization. α1c was identified as a potential target of miR-133 [7], which was 
consistent with the present findings that demonstrated a negative correlation between 
miR-133 and α1c. Taken together, it was speculated that miR-1 and miR-133 reduced 
arrhythmia by mediating the expression and activity of ion channels, and could serve 
as potential anti-arrhythmic targets. 
 
Conclusions 
In summary, this study reports that miR-1/133 mimics ameliorate cardiac function 
in VMC mice. Mechanistically, miR-1/133 mimics reduce cardiomyocyte apoptosis by 
regulating the expressions of apoptosis-related genes, improves arrhythmia through 
regulating the expressions of calcium and potassium ion channel genes of 
cardiomyocytes, and diminishes cardiac fibrosis in VMC mouse hearts. Therefore, 
miR-1/133 may serve as a potential therapeutic target for treatment of VMC in clinics. 
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Table 1. Prime sequences for qRT-PCR. 
Gene                        Primer Sequences (5’-3’)  
β-actin 
           sense             CCAGCCTTCCTTCTTGGGTAT 
antisense           TTGGCATAGAGGTCTTTACGG 
Kcnd2 
           sense             TGACAACACTGGGGTATGGC 
           antisense          CCGACTGAAGTTCGACACGA 
Kcnj2 
          sense              TCTCACTTGCTTCGGCTCAT 
          antisense           ACTTGTCCTGTTGCTGGTACA 
Irx5 
          sense              GCCTTCTCTTACGTGGGCTC 
          antisense           AGTGGCATTCTTCCGGTACG  
α1c (Cacna1c) 
          sense              TCCCGAGCACATCCCTACTC 
         antisense            ACTGACGGTAGAGATGGTTGC 
Bax 
sense               AAACTGGTGCTCAAGGCCC 
       antisense            CTTGGATCCAGACAAGCAGC 
Bcl-2  
sense              GCTACCGTCGTGACTTCGC 
       antisense            CCCACCGAACTCAAAGAAGG 
Casp9 
sense              TCAGGGGACATGCAGATATGG 
          antisense           TTGGCAGTCAGGTCGTTCTTC 
U6 
          sense              ATGACGTCTGCCTTGGAGAAC 
          antisense           TCAGTGTGCTACGGAGTTCAG 
Mmu-miR-1a-3p 
reverse transcription prime 
CTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACG
AGATACAT 
          sense            GCCGCTGGAATGTAAAGAAGT 
          antisense         GTCCGAGGTATTCGCACTGGATA 
Mmu-miR-133a-3p  
reverse transcription prime 
GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACG
ACCAGCTG 
          sense           GCTTTGGTCCCCTTCAAC  




Figure 1. Macroscopic view of hearts from different groups. A. Fluorescence showing 
specific staining of green (-actinin) and red (Dy547) for mir1/133; B. Global view of 
representative heart from each group; C. The statistical analysis of the heart 
weight/body weight ratio of mice in each group; Ctr — control group; VMC — viral 
myocarditis (VMC) group; NC — VMC + miR-1/133 negative control (NC) group; 
VMC + miR-1/133 mimics group. Data are expressed as mean ± standard error (SE). N 
= 10, **p < 0.01 vs. control group, #p < 0.05 vs. VMC and VMC + NC group; for other 
abbreviations — see text. 
 
Figure 2. MiR-1/133 mimics improved cardiac function of viral myocarditis (VMC) 
mice. A. Echocardiography showed ejection fraction (EF) and fractional shortening (FS) 
of mice in each group; a. Control group, b. VMC group, c. VMC + NC group, d. VMC + 
miR-1/133 mimics group. B. Statistical analysis of EF and FS of different groups. Data 
are expressed as mean ± standard error (SE). N = 10, **p < 0.01 vs. control group, #p < 
0.05, ##p < 0.01 vs. VMC and VMC + NC group; for other abbreviations — see text. 
 
Figure 3. MiR-1/133 mimics improved pathological changes and reduced 
cardiomyocyte apoptosis in viral myocarditis (VMC) mouse hearts. A. H&E staining 
of myocardium in different group mice (magnification: 10 × 40); a. Control group, b. 
VMC group, c. VMC + negative control (NC) group, d. VMC + miR-1/133 mimics 
group; B. TUNEL staining showed cardiomyocytes apoptosis of different group mice 
(10 × 40). Cells with brown nuclei were TUNEL positive, and cells with blue nuclei 
represented normal cells; a. Control group, b. VMC group, c. VMC+miR-1/133 NC 
group, d. VMC + miR-1/133 mimics group; C. Quantified cell apoptosis data. Data 
are expressed as mean ± standard error (SE). N = 10, **p < 0.01 vs. control, ##p < 0.01 
vs. VMC and VMC + NC group; for other abbreviations — see text. 
 
Figure 4. MiR-1/133 mimics regulated the expressions of miR-1 and miR-133, 
apoptosis-related genes, potassium channel genes and a calcium channel gene. A. The 
fold changes of miR-1 and miR-133 expression. U6 was used as an internal reference 
and data was normalized to the control group. N = 10, *p < 0.05 vs. control group, #p 
< 0.05 vs. viral myocarditis (VMC) and VMC + NC groups; B, C. The fold changes of 
apoptosis-related genes Bax, Bcl-2, and Casp9, and potassium channel genes Kcnd2, 
Irx5, Kcnj2, and L-type calcium channel subunit α1c, Cacna1c.Values were normalized 
against β-actin as an endogenous control. Data are expressed as mean ± standard error 
(SE). The fold changes of qRT-PCR were determined using the 2–ΔΔCt method. N = 10, 
*p < 0.05, **p < 0.01 vs. control group, #p < 0.05 vs. VMC and VMC + NC groups; for 
other abbreviations — see text. 
 
Figure 5. MiR-1/133 mimics complex regulated the protein levels of Kv4.2, Kir2.1 
and CaV1.2. Upper panel: Western blot. A. Control group; B. VMC group; C. VMC + 
NC group; D. VMC + miR-1/133 mimics complex group. Lower panel: statistical 
analysis of the upper panel. Data are expressed as mean ± standard error (SE). 
GAPDH was used as an internal reference, and data were normalized to the control 
group. N = 10, *p < 0.05, **p < 0.01 vs. control group, #p < 0.05 vs. VMC and VMC + 
NC groups; for other abbreviations — see text. 





